Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 381

1.

Effect of IL-33 on de novo synthesized mediators from human mast cells.

Theoharides TC, Leeman SE.

J Allergy Clin Immunol. 2018 Oct 31. pii: S0091-6749(18)31365-4. doi: 10.1016/j.jaci.2018.09.014. [Epub ahead of print] No abstract available.

PMID:
30390921
2.

Mitochondrial dysfunction in affected skin and increased mitochondrial DNA in serum from patients with psoriasis.

Therianou A, Vasiadi M, Delivanis DA, Petrakopoulou T, Katsarou-Katsari A, Antoniou C, Stratigos A, Tsilioni I, Katsambas A, Rigopoulos D, Theoharides TC.

Exp Dermatol. 2018 Nov 3. doi: 10.1111/exd.13831. [Epub ahead of print]

PMID:
30390357
3.

Substance P and IL-33 administered together stimulate a marked secretion of IL-1β from human mast cells, inhibited by methoxyluteolin.

Taracanova A, Tsilioni I, Conti P, Norwitz ER, Leeman SE, Theoharides TC.

Proc Natl Acad Sci U S A. 2018 Oct 2;115(40):E9381-E9390. doi: 10.1073/pnas.1810133115. Epub 2018 Sep 19.

PMID:
30232261
4.
5.

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome-Metabolic Disease or Disturbed Homeostasis due to Focal Inflammation in the Hypothalamus?

Hatziagelaki E, Adamaki M, Tsilioni I, Dimitriadis G, Theoharides TC.

J Pharmacol Exp Ther. 2018 Oct;367(1):155-167. doi: 10.1124/jpet.118.250845. Epub 2018 Aug 3.

PMID:
30076265
6.

Critical role of inflammatory mast cell in fibrosis: Potential therapeutic effect of IL-37.

Conti P, Caraffa A, Mastrangelo F, Tettamanti L, Ronconi G, Frydas I, Kritas SK, Theoharides TC.

Cell Prolif. 2018 Oct;51(5):e12475. doi: 10.1111/cpr.12475. Epub 2018 Jul 30. Review.

PMID:
30062695
7.

Mast cells participate in allograft rejection: can IL-37 play an inhibitory role?

Conti P, Caraffa A, Ronconi G, Kritas SK, Mastrangelo F, Tettamanti L, Frydas I, Theoharides TC.

Inflamm Res. 2018 Sep;67(9):747-755. doi: 10.1007/s00011-018-1166-3. Epub 2018 Jun 30. Review.

PMID:
29961151
8.

Time to look past TNF and thalidomide for cachexia - could mast cells and flavonoids be the answer?

King L, Tsilioni I, Theoharides TC.

J Biol Regul Homeost Agents. 2018 May-Jun;32(3):443-447. Review.

PMID:
29921368
9.

Impact of mast cells in depression disorder: inhibitory effect of IL-37 (new frontiers).

Conti P, Caraffa A, Ronconi G, Conti CM, Kritas SK, Mastrangelo F, Tettamanti L, Theoharides TC.

Immunol Res. 2018 Jun 16. doi: 10.1007/s12026-018-9004-9. [Epub ahead of print] Review.

PMID:
29907890
10.

Activated Mast Cells Mediate Low-Grade Inflammation in Type 2 Diabetes: Interleukin-37 Could Be Beneficial.

Conti P, Ronconi G, Kritas SK, Caraffa A, Theoharides TC.

Can J Diabetes. 2018 Oct;42(5):568-573. doi: 10.1016/j.jcjd.2018.01.008. Epub 2018 Jan 31. Review.

PMID:
29885882
11.

Effects of Mycotoxins on Neuropsychiatric Symptoms and Immune Processes.

Ratnaseelan AM, Tsilioni I, Theoharides TC.

Clin Ther. 2018 Jun;40(6):903-917. doi: 10.1016/j.clinthera.2018.05.004. Epub 2018 Jun 5. Review.

PMID:
29880330
12.

Mold and Immunity.

Theoharides TC.

Clin Ther. 2018 Jun;40(6):882-884. doi: 10.1016/j.clinthera.2018.05.005. Epub 2018 May 30. No abstract available.

PMID:
29859636
13.

Interleukin 33 and interleukin 4 regulate interleukin 31 gene expression and secretion from human laboratory of allergic diseases 2 mast cells stimulated by substance P and/or immunoglobulin E.

Petra AI, Tsilioni I, Taracanova A, Katsarou-Katsari A, Theoharides TC.

Allergy Asthma Proc. 2018 Mar 1;39(2):153-160. doi: 10.2500/aap.2018.38.4105.

14.

Reply to Fattori et al.: Action of SP and IL-33 on mast cells.

Theoharides TC, Taracanova A, Tsilioni I, Conti P, Leeman SE.

Proc Natl Acad Sci U S A. 2017 Nov 21;114(47):E10036. doi: 10.1073/pnas.1716233114. Epub 2017 Nov 6. No abstract available.

15.

TNF stimulates IL-6, CXCL8 and VEGF secretion from human keratinocytes via activation of mTOR, inhibited by tetramethoxyluteolin.

Patel AB, Tsilioni I, Weng Z, Theoharides TC.

Exp Dermatol. 2018 Feb;27(2):135-143. doi: 10.1111/exd.13461. Epub 2018 Jan 3.

PMID:
29105195
16.

Impact of mast cells in mucosal immunity of intestinal inflammation: Inhibitory effect of IL-37.

Conti P, Caraffa A, Ronconi G, Kritas SK, Mastrangelo F, Tettamanti L, Theoharides TC.

Eur J Pharmacol. 2018 Jan 5;818:294-299. doi: 10.1016/j.ejphar.2017.09.044. Epub 2017 Sep 29. Review.

PMID:
28970014
17.

Link between mast cells and bacteria: Antimicrobial defense, function and regulation by cytokines.

Conti P, Carinci F, Caraffa A, Ronconi G, Lessiani G, Theoharides TC.

Med Hypotheses. 2017 Sep;106:10-14. doi: 10.1016/j.mehy.2017.06.018. Epub 2017 Jun 29.

PMID:
28818263
18.

Potential therapeutic use of IL-37: a key suppressor of innate immunity and allergic immune responses mediated by mast cells.

Conti P, Carinci F, Lessiani G, Spinas E, Kritas SK, Ronconi G, Caraffa A, Theoharides TC.

Immunol Res. 2017 Oct;65(5):982-986. doi: 10.1007/s12026-017-8938-7. Review.

PMID:
28748328
19.

Mast cell, pro-inflammatory and anti-inflammatory: Jekyll and Hyde, the story continues.

Conti P, Caraffa Al, Kritas SK, Ronconi G, Lessiani G, Toniato E, Theoharides TC.

J Biol Regul Homeost Agents. 2017 Apr-Jun;31(2):263-267. Review.

PMID:
28685525
20.

Tolerability and benefit of a tetramethoxyluteolin-containing skin lotion.

Theoharides TC, Stewart JM, Tsilioni I.

Int J Immunopathol Pharmacol. 2017 Jun;30(2):146-151. doi: 10.1177/0394632017707610. Epub 2017 May 8.

21.

SP and IL-33 together markedly enhance TNF synthesis and secretion from human mast cells mediated by the interaction of their receptors.

Taracanova A, Alevizos M, Karagkouni A, Weng Z, Norwitz E, Conti P, Leeman SE, Theoharides TC.

Proc Natl Acad Sci U S A. 2017 May 16;114(20):E4002-E4009. doi: 10.1073/pnas.1524845114. Epub 2017 May 1.

22.

Vitamin D and Atopy.

Theoharides TC.

Clin Ther. 2017 May;39(5):880-883. doi: 10.1016/j.clinthera.2017.03.002. Epub 2017 Apr 26. No abstract available.

PMID:
28454657
23.

Mast cells emerge as mediators of atherosclerosis: Special emphasis on IL-37 inhibition.

Conti P, Lessiani G, Kritas SK, Ronconi G, Caraffa A, Theoharides TC.

Tissue Cell. 2017 Jun;49(3):393-400. doi: 10.1016/j.tice.2017.04.002. Epub 2017 Apr 12. Review.

PMID:
28420489
24.

Methoxyluteolin Inhibits Neuropeptide-stimulated Proinflammatory Mediator Release via mTOR Activation from Human Mast Cells.

Patel AB, Theoharides TC.

J Pharmacol Exp Ther. 2017 Jun;361(3):462-471. doi: 10.1124/jpet.117.240564. Epub 2017 Apr 12.

25.

Neuroendocrinology of mast cells: Challenges and controversies.

Theoharides TC.

Exp Dermatol. 2017 Sep;26(9):751-759. doi: 10.1111/exd.13288. Epub 2017 Apr 2. Review.

PMID:
28094875
26.

Neurotensin stimulates sortilin and mTOR in human microglia inhibitable by methoxyluteolin, a potential therapeutic target for autism.

Patel AB, Tsilioni I, Leeman SE, Theoharides TC.

Proc Natl Acad Sci U S A. 2016 Nov 8;113(45):E7049-E7058. doi: 10.1073/pnas.1604992113. Epub 2016 Sep 23. Erratum in: Proc Natl Acad Sci U S A. 2016 Nov 1;:.

27.
28.

Endocrinology of the skin: intradermal neuroimmune network, a new frontier.

Caraffa A, Spinas E, Kritas SK, Lessiani G, Ronconi G, Saggini A, Antinolfi P, Pizzicannella J, Toniato E, Theoharides TC, Conti P.

J Biol Regul Homeost Agents. 2016 Apr-Jun;30(2):339-43.

PMID:
27358119
29.

Atopic diseases and inflammation of the brain in the pathogenesis of autism spectrum disorders.

Theoharides TC, Tsilioni I, Patel AB, Doyle R.

Transl Psychiatry. 2016 Jun 28;6(6):e844. doi: 10.1038/tp.2016.77. Review.

30.

Neuroendocrinology of the skin.

Theoharides TC, Stewart JM, Taracanova A, Conti P, Zouboulis CC.

Rev Endocr Metab Disord. 2016 Sep;17(3):287-294. Review.

PMID:
27338934
31.

Mast Cells Regulate Wound Healing in Diabetes.

Tellechea A, Leal EC, Kafanas A, Auster ME, Kuchibhotla S, Ostrovsky Y, Tecilazich F, Baltzis D, Zheng Y, Carvalho E, Zabolotny JM, Weng Z, Petra A, Patel A, Panagiotidou S, Pradhan-Nabzdyk L, Theoharides TC, Veves A.

Diabetes. 2016 Jul;65(7):2006-19. doi: 10.2337/db15-0340. Epub 2016 Apr 8.

32.

Danger Signals and Inflammation.

Theoharides TC.

Clin Ther. 2016 May;38(5):996-9. doi: 10.1016/j.clinthera.2016.03.036. Epub 2016 Apr 22. No abstract available.

PMID:
27101818
33.

Nanotube Formation: A Rapid Form of "Alarm Signaling"?

Weng Z, Zhang B, Tsilioni I, Theoharides TC.

Clin Ther. 2016 May;38(5):1066-72. doi: 10.1016/j.clinthera.2016.02.030. Epub 2016 Apr 13.

PMID:
27085584
34.

Post-Lyme Syndrome-Associated Polyneuropathy Treated With Immune Immunoglobulin and a Luteolin-Containing Formulation.

Theoharides TC, Stewart JM.

J Clin Psychopharmacol. 2016 Jun;36(3):290-1. doi: 10.1097/JCP.0000000000000504. No abstract available.

PMID:
27035494
35.

Skin mast cells: are we missing the forest for the trees?

Theoharides TC.

Exp Dermatol. 2016 Jun;25(6):422-3. doi: 10.1111/exd.13008. Epub 2016 May 16. No abstract available.

PMID:
26998580
36.

Antihistamines and Mental Status.

Theoharides TC, Stewart JM.

J Clin Psychopharmacol. 2016 Jun;36(3):195-7. doi: 10.1097/JCP.0000000000000483. No abstract available.

PMID:
26974123
37.

Genitourinary mast cells and survival.

Theoharides TC, Stewart JM.

Transl Androl Urol. 2015 Oct;4(5):579-86. doi: 10.3978/j.issn.2223-4683.2015.10.04. Review.

38.

Neuropeptides CRH, SP, HK-1, and Inflammatory Cytokines IL-6 and TNF Are Increased in Serum of Patients with Fibromyalgia Syndrome, Implicating Mast Cells.

Tsilioni I, Russell IJ, Stewart JM, Gleason RM, Theoharides TC.

J Pharmacol Exp Ther. 2016 Mar;356(3):664-72. doi: 10.1124/jpet.115.230060. Epub 2016 Jan 13.

39.

Mast Cells, Mastocytosis, and Related Disorders.

Theoharides TC, Valent P, Akin C.

N Engl J Med. 2015 Nov 5;373(19):1885-6. doi: 10.1056/NEJMc1510021. No abstract available.

40.

Children with autism spectrum disorders, who improved with a luteolin-containing dietary formulation, show reduced serum levels of TNF and IL-6.

Tsilioni I, Taliou A, Francis K, Theoharides TC.

Transl Psychiatry. 2015 Sep 29;5:e647. doi: 10.1038/tp.2015.142.

41.

Mast cells in meningiomas and brain inflammation.

Polyzoidis S, Koletsa T, Panagiotidou S, Ashkan K, Theoharides TC.

J Neuroinflammation. 2015 Sep 17;12:170. doi: 10.1186/s12974-015-0388-3. Review.

42.

Fibromyalgia syndrome in need of effective treatments.

Theoharides TC, Tsilioni I, Arbetman L, Panagiotidou S, Stewart JM, Gleason RM, Russell IJ.

J Pharmacol Exp Ther. 2015 Nov;355(2):255-63. doi: 10.1124/jpet.115.227298. Epub 2015 Aug 25. Review.

43.

Brain "fog," inflammation and obesity: key aspects of neuropsychiatric disorders improved by luteolin.

Theoharides TC, Stewart JM, Hatziagelaki E, Kolaitis G.

Front Neurosci. 2015 Jul 3;9:225. doi: 10.3389/fnins.2015.00225. eCollection 2015. Review.

44.

Mast Cells, Mastocytosis, and Related Disorders.

Theoharides TC, Valent P, Akin C.

N Engl J Med. 2015 Jul 9;373(2):163-72. doi: 10.1056/NEJMra1409760. Review. No abstract available.

PMID:
26154789
45.

Gut-Microbiota-Brain Axis and Its Effect on Neuropsychiatric Disorders With Suspected Immune Dysregulation.

Petra AI, Panagiotidou S, Hatziagelaki E, Stewart JM, Conti P, Theoharides TC.

Clin Ther. 2015 May 1;37(5):984-95. doi: 10.1016/j.clinthera.2015.04.002. Review.

46.

On the Gut Microbiome-Brain Axis and Altruism.

Theoharides TC.

Clin Ther. 2015 May 1;37(5):937-40. doi: 10.1016/j.clinthera.2015.04.003. No abstract available.

PMID:
26046239
47.

Mast cells, brain inflammation and autism.

Theoharides TC, Stewart JM, Panagiotidou S, Melamed I.

Eur J Pharmacol. 2016 May 5;778:96-102. doi: 10.1016/j.ejphar.2015.03.086. Epub 2015 May 1. Review.

PMID:
25941080
48.

Targeting IL-33 in autoimmunity and inflammation.

Theoharides TC, Petra AI, Taracanova A, Panagiotidou S, Conti P.

J Pharmacol Exp Ther. 2015 Jul;354(1):24-31. doi: 10.1124/jpet.114.222505. Epub 2015 Apr 23. Review.

49.

Mast cells promote malaria infection?

Theoharides TC.

Clin Ther. 2015 Jun 1;37(6):1374-7. doi: 10.1016/j.clinthera.2015.03.014. Epub 2015 Apr 1.

PMID:
25840471
50.

Dysregulated brain immunity and neurotrophin signaling in Rett syndrome and autism spectrum disorders.

Theoharides TC, Athanassiou M, Panagiotidou S, Doyle R.

J Neuroimmunol. 2015 Feb 15;279:33-8. doi: 10.1016/j.jneuroim.2014.12.003. Epub 2014 Dec 4. Review.

PMID:
25669997

Supplemental Content

Loading ...
Support Center